These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Anticardiolipin antibodies and interleukin-6 in cerebrospinal fluid and blood of Chinese patients with neuro-Behçet's syndrome. Wang CR, Chuang CY, Chen CY. Clin Exp Rheumatol; 1992 Mar; 10(6):599-602. PubMed ID: 1483312 [Abstract] [Full Text] [Related]
4. Anticardiolipin (aCL) antibodies in a patient with Behçet's syndrome with vena cava inferior thrombosis. Ebo DG, Bracke PG, De Clerck LS, Francx LM, Stevens WJ. Clin Rheumatol; 1997 Jan; 16(1):96-8. PubMed ID: 9132335 [Abstract] [Full Text] [Related]
7. Anticardiolipin antibodies and retinal vascular complications in Behçet's disease. Ozdemir Y, Onder F, Yarangümeli A, Küçükkuyumcu C, Kural G. Ophthalmic Surg Lasers; 1997 Aug; 28(8):653-6. PubMed ID: 9268996 [Abstract] [Full Text] [Related]
8. Anticardiolipin antibodies in uveitis. Klok AM, Geertzen R, Rothova A, Baarsma GS, Kijlstra A. Curr Eye Res; 1992 Aug; 11 Suppl():209-13. PubMed ID: 1424747 [Abstract] [Full Text] [Related]
9. Clinical significance of immunoglobulin A versus immunoglobulins G and M anti-cardiolipin antibodies in patients with systemic lupus erythematosus. Correlation with thrombosis, thrombocytopenia, and recurrent abortion. Lopez LR, Santos ME, Espinoza LR, La Rosa FG. Am J Clin Pathol; 1992 Oct; 98(4):449-54. PubMed ID: 1415024 [Abstract] [Full Text] [Related]
11. Prevalence of anticardiolipin antibodies in patient cohorts with distinct clinical manifestations of the antiphospholipid syndrome. Damoiseaux J, Peeters L, Hupperts R, Boreas A, ten Cate H, Tervaert JW. Ann N Y Acad Sci; 2009 Sep; 1173():146-51. PubMed ID: 19758143 [Abstract] [Full Text] [Related]
13. Analysis of risk factors and comorbid diseases in the development of thrombosis in patients with anticardiolipin antibodies. Sairam S, Baethge BA, McNearney T. Clin Rheumatol; 2003 Feb; 22(1):24-9. PubMed ID: 12605313 [Abstract] [Full Text] [Related]
14. Characteristics of neurological manifestations of Behçet's disease: a retrospective monocentric study in Tunisia. Houman MH, Bellakhal S, Ben Salem T, Hamzaoui A, Braham A, Lamloum M, Monia SK, Ben Ghorbel I. Clin Neurol Neurosurg; 2013 Oct; 115(10):2015-8. PubMed ID: 23830180 [Abstract] [Full Text] [Related]
17. Anticardiolipin antibodies, a disease marker for ischemic cerebrovascular events in a younger patient population? Czlonkowska A, Meurer M, Palasik W, Baranska-Gieruszczak M, Mendel T, Wierzchowska E. Acta Neurol Scand; 1992 Sep; 86(3):304-7. PubMed ID: 1414251 [Abstract] [Full Text] [Related]
18. Antiannexin V autoantibody in thrombophilic Behçet's disease. Aslan H, Pay S, Gok F, Baykal Y, Yilmaz MI, Sengul A, Aydin HI. Rheumatol Int; 2004 Mar; 24(2):77-9. PubMed ID: 14658002 [Abstract] [Full Text] [Related]